Press Releases
Lee Seeks Increased Competition in Biological Drug Market
Jul 13, 2023
Sens. Mike Lee (R-UT), Ben Ray Lujan (R-NM), Mike Braun (R-IN), and J.D. Vance (R-OH) introduced the Biosimilar Red Tape Elimination Act to increase competition within the biological drug market and increase access to low-cost prescription drugs.
No TSP Funding for Woke ESG
Jun 23, 2023
Sens. Mike Lee (R-UT) and Rick Scott (R-FL) introduced the No ESG at TSP Act, crucial legislation to safeguard taxpayer dollars from ideologically driven investment funds. Representative Chip Roy (R-TX) introduced a companion bill in the House of Representatives. The bill addresses the growing concerns surrounding Environmental, Social, and Governance (ESG) initiatives, which pose risks to our domestic energy supply and promotes divisive ideological agendas.
Senators: BlackRock’s ESG Activism Harms Americans
Jun 23, 2023
Sen. Mike Lee (R-UT) and 10 of his Senate colleagues sent a letter to Chairman Phillips and Commissioners urging the Federal Energy Regulatory Commission (the "Commission") to investigate the actions of BlackRock, the world's largest asset manager, regarding its commitments to the Commission and its influence on utility operations.
Putting Patients First: Lee Spearheads Islet Transplantation Bill
Jun 22, 2023
Sens. Mike Lee (R-UT), Ted Budd (R-NC), and Marsha Blackburn (R-TN) introduced a bill aimed at empowering patients and improving the outdated regulation of islet transplantation, a cutting-edge treatment for individuals with Type 1 Diabetes. Rep. Matt Rosendale (R-MT) introduced a companion bill in the House of Representatives. Focused on patient-centered care, this effort would move islets to a more appropriate regulatory framework.
